Clean Science and Technology shares surged 2% following the announcement that its subsidiary, Clean Fino-Chem Limited (CFCL), has begun the commercial production of 2,5-Dihydroxy-1,4-Dithiane (DHDT).
This new production marks a significant milestone for the company, as it becomes a key domestic manufacturer of DHDT, driving import substitution demand.
Clean Science shares opened at 1,395.10, reaching a high of 1,432.20 and a low of 1,392.35 during the trading session. The stock has shown strong performance over the past year, with a 52-week high of 1,690.00 and a low of 1,243.00.
The commercialization of DHDT also strengthens Clean Science’s pharma segment by offering cross-selling opportunities with Dicyclohexylcarbodimide (DCC) customers. Furthermore, the company has developed DHDT using innovative chlorination chemistry, expanding its chemistry capabilities.
Disclaimer: The information provided is for informational purposes only and should not be considered financial or investment advice. Stock market investments are subject to market risks. Always conduct your own research or consult a financial advisor before making investment decisions. Author or Business Upturn is not liable for any losses arising from the use of this information.
